March Expert Series – MELAS Spectrum Disorders and Sonlicromanol: Progress Update
Join MitoAction and Dr. Jan Smeitink, CEO of Khondrion for our March Expert Series presentation. MELAS spectrum (m.3243A>G) disorders belong to the most frequently encountered group of primary mitochondrial diseases […]